Migraine Disorders Clinical Trial
— PNFOfficial title:
Efficacy of Proprioceptive Neuromuscular Facilitation in Pain Relief in Women With Migraine
Verified date | March 2018 |
Source | Universidade Federal de Pernambuco |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
The purpose of this study is to determine whether the contract-relax technique of proprioceptive neuromuscular facilitation, and the static stretching exercise are effective in reducing the frequency, intensity and duration of headache and in improving the perception of quality of life in women with migraine.
Status | Completed |
Enrollment | 30 |
Est. completion date | August 2017 |
Est. primary completion date | August 2017 |
Accepts healthy volunteers | No |
Gender | Female |
Age group | 18 Years to 40 Years |
Eligibility |
Inclusion Criteria: - Age between 18and 40 years - Clinical diagnosis of migraine - Participants with at least one day with acute migraine per month, with attacks lasting 4-72 hours. Exclusion Criteria: - Obesity type I, II or III, according to the classification of Body Mass Index. - Pregnancy, lactation or both. - Presence of meningitis, demyelinating diseases, cerebral aneurysm, intracranial hypertension, myopathies, myelopathy, fibromyalgia, symptomatic neck disc herniation, rheumatoid arthritis and history of tumors in the brain or spine. - Participants who performed other manual therapeutic interventions or other physical therapy modalities in the head or neck during the survey period. - Participants who have daily prophylactic medication for migraine. |
Country | Name | City | State |
---|---|---|---|
Brazil | Departamento de Fisioterapia da Universidade Federal de Pernambuco | Recife | Pernambuco |
Lead Sponsor | Collaborator |
---|---|
Universidade Federal de Pernambuco |
Brazil,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Pain change | "Daily headache" | "Change from Baseline Pain at 8th - 10th week"; "Change from Baseline Pain at 12th - 14th week" | |
Primary | The global perception of change | "Patient Global Impression of Change Scale" | "global perception of change at 12th - 14th week" | |
Primary | Feasibility for successful random allocation | "successful random allocation of 30 patients during a 12-months period" | "12 months" | |
Primary | Proportion of eligible patients randomly assigned for each group (target =70%) | "the proportion of eligible patients randomly assigned for each group (target =70%)" | "12 months" | |
Primary | Proportion of eligible patients who completed 30-day follow-up (target =95%) | "the proportion of randomly assigned patients who completed 30-day follow-up after the end of the treatment (target =95%)" | "12 months" | |
Secondary | Change in Medicine intake in migraine attacks | "Daily headache" | "Change from Baseline Medicine intake at 8th - 10th week"; "Change from Baseline Medicine intake at 12th - 14th week" | |
Secondary | Change in Adverse effects of the intervention | Daily headache | "Change from Baseline adverse effects at 8th - 10th week"; "Change from Baseline adverse effects at 12th - 14th week" | |
Secondary | Change in Neck mobility | Goniometer "Cervical Range of Motion (CROM)" | "Change from Baseline neck mobility at 8th - 10th week"; "Change from Baseline neck mobility at 12th - 14th week" | |
Secondary | Change in pressure pain threshold | "Computerized Algometer" | "Change from Baseline pressure pain threshold at 8th - 10th week"; "Change from Baseline pressure pain threshold at 12th - 14th week" | |
Secondary | Change in neck disability index | Questionnaire "Neck disability index" | "Change from Baseline neck disability index at 8th - 10th week"; "Change from Baseline neck disability index at 12th - 14th week" | |
Secondary | Change in severity of migraine-related disability | Questionnaire "Migraine disability assessment" | "Change from Baseline Migraine disability assessment at 8th - 10th week"; "Change from Baseline Migraine disability assessment at 12th - 14th week" |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT01432379 -
BOTOX® Prophylaxis in Patients With Chronic Migraine
|
||
Completed |
NCT04084314 -
Assessment of Prolonged Safety and tOLerability of in Migraine Patients in a Long-term OpeN-label Study
|
Phase 4 | |
Recruiting |
NCT05048914 -
Migraine Abortive Treatment
|
||
Completed |
NCT03662295 -
Stroke-like Migraine Attacks After Radiation Treatment (SMART) Syndrome Language Intervention
|
||
Completed |
NCT02766517 -
Biomarker Study in Participants With Migraine
|
Early Phase 1 | |
Completed |
NCT00963937 -
Study to Evaluate the Efficacy and Safety of Oral Sumatriptan for the Acute Treatment of Migraine in Children and Adolescents
|
Phase 3 | |
Not yet recruiting |
NCT03632928 -
Day to Day Variation of Pressure Pain Threshold and Muscle Hardness
|
||
Completed |
NCT02559895 -
A Multicenter Assessment of ALD403 in Frequent Episodic Migraine
|
Phase 3 | |
Completed |
NCT01435941 -
Non-steroidal Anti-inflammatory Drugs Alone or With a Triptan and Reports of Transition From Episodic to Chronic Migraine
|
N/A | |
Completed |
NCT00743015 -
Relative Bioavailability of a Single Dose of BI 44370 Tablet During and Between Migraine Attacks
|
Phase 1 | |
Completed |
NCT01376141 -
Drug Use Investigation for IMIGRAN Tablet
|
N/A | |
Completed |
NCT02183688 -
Acetylsalicylic Acid (ASA) + Paracetamol + Caffeine Combination Compared With ASA + Paracetamol as Well as ASA, Paracetamol, and Caffeine in Headache Patients
|
Phase 3 | |
Completed |
NCT06061588 -
"Potential Effects of Virtual Reality Technology on the Treatment of Migraine-Type Headaches"
|
N/A | |
Completed |
NCT03588364 -
The Role of Osteopathic Manipulation in the the Management of Post-traumatic Migraine
|
N/A | |
Completed |
NCT04091321 -
Association Between Chronic Headache and Back Pain With Childbirth
|
||
Completed |
NCT00385008 -
TREXIMA and RELPAX Gastric Scintigraphy Inside and Outside a Migraine
|
Phase 3 | |
Active, not recruiting |
NCT05888298 -
Proximal and Distal Approach GON RFT in Migraine
|
N/A | |
Completed |
NCT03435185 -
Greater Occipital and Supraorbital Nerve Blockade in Migraine Patients
|
N/A | |
Recruiting |
NCT06459635 -
Migraine Attack Pain Phase Prediction Study
|
||
Completed |
NCT02565186 -
An Open-label, Long-term, Safety Study of Lasmiditan for the Acute Treatment of Migraine
|
Phase 3 |